Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
Positive early results in clinical trial for DNA vaccine
Positive early results in clinical trial for DNA vaccine
ASH 2012: Exercise benefit to lifespan may be due to stem cell increase
ASH 2012: Exercise benefit to lifespan may be due to stem cell increase
ASH 2012: Histone deacetylases targeted as new strategy against graft versus host disease
ASH 2012: Histone deacetylases targeted as new strategy against graft versus host disease
ASH 2012: Pomalidomide with low-dose dexamethasone demonstrates significant progression free survival and overall survival advantage for relapsed/refractory multiple myeloma
ASH 2012: Pomalidomide with low-dose dexamethasone demonstrates significant progression free survival and overall...
ASH 2012: New proteasome inhibitor MLN9708 increases efficacy of treatment for multiple myeloma
ASH 2012: New proteasome inhibitor MLN9708 increases efficacy of treatment for multiple myeloma
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
ASH 2012: Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant
ASH 2012: Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant
ASH 2012: Engineered immune cells produce complete response in child with an aggressive paediatric leukaemia
ASH 2012: Engineered immune cells produce complete response in child with an aggressive paediatric leukaemia
ASH 2012: First curative treatment for acute promyelocytic leukaemia that does not include chemotherapy
ASH 2012: First curative treatment for acute promyelocytic leukaemia that does not include chemotherapy
ASH 2012: Daunorubicin not required in initial regimen for children with standard-risk acute lymphocytic leukaemia
ASH 2012: Daunorubicin not required in initial regimen for children with standard-risk acute lymphocytic leukaemia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation